Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial
Eric L. Simpson, Lawrence F. Eichenfield,Kim A. Papp,Seth B. Forman,Adelaide A. Hebert,Mercedes E. Gonzalez, Melinda J. Gooderham,H. Chih-ho Hong,Vimal H. Prajapati,Emma Guttman-Yassky, Jonathan I. Silverberg,Melissa S. Seal,David Krupa, Erin Almaraz,Diane Hanna,Patrick Burnett,Scott Snyder,David H. Chu,Robert C. Higham,David R. Berk DERMATITIS（2025）
AI 理解论文
溯源树
样例
